ISAC shares concerns about the Hydroxychloroquine and Azithromycin paper

The International Society of Antimicrobial Chemotherapy (ISAC) has shared concerns about the Gautret et al. paper published in its own journal. This paper, published under senior authorship of Didier Raoult from the IHU-Méditerranée Infection in Marseille, describes a small study that showed remarkable effects of Hydroxychloroquine and Azithromycin treatment in COVID-19 patients.

After world leaders and politicians started to tweet and endorse this study, many people pressured health officials to start treating COVID-19 patients with this regime, although the study was small and not yet confirmed by independent, larger, and better randomized other studies.

Several scientists and medical professionals, including myself, had concerns about how patients were assigned to each treatment group, how PCR results were reported, why patients with a poor outcome had been left out of the final results, and how this treatment could potentially result in serious side effects. I wrote about my concerns in this blogpost and on PubPeer.

Now, ISAC, who is overseeing the International Journal of Antimicrobial Agents, the journal that published this study, has joined in those concerns.

Continue reading “ISAC shares concerns about the Hydroxychloroquine and Azithromycin paper”

An observational study without a control group

This blog post is based on a Twitter thread I did on March 27, 2020, after seeing Mathieu Rebeaud’s Tweet about a new white paper from the institute of Didier Raoult. That not-yet peer reviewed paper describes a group of 80 COVID-19 patients, all treated with a combination of hydroxychloroquine and azithromycin. This treatment had shown some promising results in a very small, not well-executed study by the same group. Unfortunately, this second study does not have a control group and the patients did not appear to be very sick. So here is my critical review.

Continue reading “An observational study without a control group”

Some critical notes on a COVID-19 TCM paper

The recent COVID-19 outbreak has led to an enormous amount of preprints and rapidly-approved papers of variable quality. A recently published paper in Pharmacological Research called “Traditional Chinese Medicine for COVID-19 Treatment” caught my eye. The title suggested that Traditional Chinese Medicine (TCM) could be used to treat patients that had fallen ill with the viral disease, but a quick read showed that the paper promised much more than it delivered. Here is a critical review.

Continue reading “Some critical notes on a COVID-19 TCM paper”

Photoshop as a management modality

On Twitter, @DrVanDamme pointed me to a paper in published in July 2019 in the International Journal of Oral and Maxillofacial Surgery, a journal of the International Association of Oral and Maxillofacial Surgeons (IAOMS).

Continue reading “Photoshop as a management modality”

Concerns about a paper on HPV vaccination and pregnancy rates

A short post based on a Twitter thread I wrote today about a paper I had seen a while ago. You can also read the ThreadReaderApp post, which many people find easier to read.

A couple of weesk ago, I saw a social media post claiming that the HPV vaccine would cause infertility in women, based on results in a peer-reviewed paper. It sounded hard to believe, because many other studies have found that the HPV vaccine is safe to use. There was no time that day to look up the details and I let it go.

Continue reading “Concerns about a paper on HPV vaccination and pregnancy rates”